Paige AI, Inc.
Led by a team of experts in the fields of life sciences, oncology, pathology, technology, machine learning, and healthcare, Paige strives to transform cancer diagnostics. We make it possible not only to provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and confidently, but also to go beyond by extracting novel insights from digital slides that can’t be seen by the naked eye. These unique tissue signatures have the potential to help guide treatment decisions and enable the development of novel biomarkers from tissues for diagnostic, pharmaceutical and life sciences companies. Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale.
Company details
Find locations served, office locations
- Business Type:
- Software vendor
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
About Us
Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options.
Our Mission
How we support our mission
- Esteemed leadership
- Led by a team of experts in pathology, machine learning and healthcare
- Improving traditional pathology
- Software that provides additional information on every slide
- Helps Pathologists work efficiently and confidently
- Paving the future of pathology
- Advanced software to extract new information from pathology slides for additional information to create the most informed and personalized patient treatment workflows possible
- Commitment to making an impact
- Empowering pathologists and transforming oncology